KaloBios Pharmaceuticals, which has been trying to shake off the shadow of ex-CEO Martin Shkreli, has lined up bankruptcy financing that is premised on tamping down his stake in the company.
from WSJ.com: US Business http://ift.tt/21nyMQD
via IFTTT
No comments:
Post a Comment